CanStem111P trial: A Phase 3 Study of napabucasin (NAPA) plus nab-paclitaxel (nPTX) with gemcitabine (Gem) in adult patients with metastatic pancreatic adenocarcinoma (mPDAC) - Trial in progress

T. Bekaii-Saab, T. Okusaka, D. Goldstein, B. O'Neill, J. Tabernero, C. Li, M. Reni, B. Jin, C. Oh, L. Borodyansky, E. Van Cutsem

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)v51-v52
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
StatePublished - Jun 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this